Study data indicate that checkpoint inhibitors combined with radiation could improve survival for patients with melanoma-related brain metastases.
Although involved-field radiotherapy (IFRT) has a high level of disease control in patients with follicular lymphoma, relapse frequently occurs; therefore, researchers sought to determine if adding chemotherapy would improve progression-free survival.
Greater reproducibility and higher concordance for melanoma staging observed with implementation of AJCC 8.
In this study, researchers investigated the effects of exercise on physical and psychological recovery after autoHSCT for multiple myeloma.
Researchers employed a literature search and in-person qualitative interviews to determine the key elements to successful NP-physician comanagement.
Although corticosteroids are frequently used to manage adverse effects (AEs), data on AEs related to these agents are lacking. Therefore, these researchers sought to determine if better reporting of corticosteroid-related AEs would be of benefit.
In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.
Using data from the NHS and the HPFS, researchers investigated the association between polyunsaturated fat, cholesterol, and monounsaturated fat intake and risks for SCC, melanoma, and BCC.
Researchers sought to determine if handgrip force could provide objective measures of CRF in patients with cancer.
The effectiveness of a novel intervention intended to reduce and/or prevent depression in patients with advanced cancer at the end of life was investigated in a randomized study with more than 300 patients.
Higher rate of recall, lower sensitivity, larger tumor diameter, and more lymph node-positive disease observed in women with dense breasts.
Using a comparator group, researchers sought to determine the impact of a diagnosis of solid tumor on outcomes among postsurgical ICU admissions in patients with cancer vs those without cancer.
Mindfulness-based interventions are proven effective in helping patients with cancer manage distress and other psychological symptoms. In this study, researchers sought to determine if Internet-based MBCT can be as effective as face-to-face interventions.
Post-traumatic stress symptoms are linked to a greater symptom burden in hospitalized cancer patients.
In this retrospective study, researchers sought to determine the effectiveness of fentanyl for dyspnea in dying patients with advanced cancer.
A retrospective study sought to evaluate outcomes for patients with CLL who were treated with FCR, a highly effective treatment, and initially had refractory disease, experienced relapse early, or were unable to complete therapy due to toxicity.
Researchers examine the possible impact that opioid products marketed by the pharmaceutical industry may have on clinician prescribing rates.
In a retrospective study, researchers used established tools to measure the nutritional status of patients with head and neck cancer before, immediately after, and at 2 follow-up points after radiotherapy.
Researchers report on a study to determine the relationship between BMI and risk for breast cancer among younger women, particularly those 18 to 24 years old.
Three-drug regimen twice a week achieved good response and long-term outcomes in patients with newly diagnosed multiple myeloma; however, regimen has higher toxicity than once weekly dose.
In a poster presentation at the 23rd Congress of EHA, researchers described a study of the efficacy of romiplastim in achieving a platelet response in pediatric patients with immune thrombocytopenia.
Adherence is a challenge for many patients receiving oral chemotherapy, new data suggests a potential solution.
In this study, researchers assigned 75 patients with newly diagnosed Philadelphia chromosome (Ph)-positive CML-CP to receive dasatinib 50 mg once daily.
Mistrust in clinical research and social vulnerability appear to play major roles in resistance to breast cancer screening.
Some patients may be at risk for receiving end-of-life care that is not congruent with their preferences and goals.
Nurses can play a key role in assessing financial strain and involving social workers or financial counselors.
The 18-month progression-free survival rate was 71.6% among patients treated with daratumumab plus VMP compared with 50.2% among patients treated with VMP alone.
A total of 494,189 men and women aged 20 to 70 years without diabetes and with no history of cancer were followed to evaluate cancer and diabetes development.
Psychological impairment seen particularly in survivors with chronic health conditions.
Researchers conducted a prospective real-life analysis to determine the effects of trabectedin plus PLD in patients with platinum-sensitive recurrent ovarian cancer.
With Theresa Ann Lown, BSN, RN. OCN, ONN-CG
Various CBCT programs seek to address clinician burnout and compassion fatigue.
With Nik Buescher
With Jennifer Ibe, BSN, RN, OCN
With Judy B. Koutlas, RN, MS, OCN
With Dan Sherman, LCSW
With Kelly J. Brassil, PhD, RN, AOCNS, ACNSBC
With Rosemarie A. Tucci, RN, MSN, AOCN
An in-depth review of 2 navigation systems, presented at the 2018 ONA Navigation Summit, identified the challenges and solutions that can build effective, efficient programs that ensure patients have access to the care and resources they need to achieve their goals throughout their cancer journey.
There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.
Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.
A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.
Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.
The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.
Creating a multidisciplinary breast clinic can ensure that patients with breast cancer receive care that is timely, effective, and efficient, according to a presentation at the 2018 ONA Navigation Summit.
Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator
The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.
The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.
Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
A discussion and review of how to develop a successful nurse or patient navigation program is presented at the 2018 ONA Navigation Summit.
Oncology nurse navigators tend to forget the most important person in the cancer care continuum: themselves. In this keynote presentation at the 2018 ONA Navigation Summit, Deborah Boyle, RN, MSN, AOCNS®, FAAN, talks about the importance of self care.
Now well established within the cancer care continuum, this presentation at the 2018 ONA Navigation Summit discussed the forces expanding the use of oncology navigation as well as the evolving role of the oncology nurse navigator.
Results of a prospective phase 3 study demonstrated noninferiority of R-THP-COP for diffuse large B cell lymphoma to the standard of care, suggesting the regimen may be an alternative option for these patients.
Researchers report on a retrospective cohort analysis that evaluated the long-term effects of vigorous exercise for survivors of childhood cancer.
In a prospective, longitudinal study, researchers investigated the potential for quality of life, fatigue, and physical functioning to return to previous levels in patients with AML after treatment.
Clinicians have an important role to play in providing support and guidance for caregivers.
A sizable number of breast cancer survivors do not undergo annual surveillance.
Interventions specifically designed to target cachexia in patients with thoracic or gastrointestinal cancer and established cachexia were effective in helping patients preserve functional stability and rehabilitation potential.
Researchers explored connections between overall survival and adjuvant radiotherapy when factoring in CTC status.
Using SEER-CAHPS data and experience surveys, researchers sought to determine perception of timeliness and quality of care among patients in urban areas vs those in rural areas.
After adjusting for confounding factors,a significantly decreased risk for subsequent AD was reported among patients with malignant melanoma.
FDA approval was based on results of the single-arm phase 2 JULIET clinical trial.
A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
A personalized therapy can mediate complete durable cancer regression, according to study results.
Tazemetostat demonstrated preclinical activity against EZH2-mutant non-Hodgkin lymphomas.
In a retrospective study, researchers investigated the effect of primary prophylaxis on incidence of febrile neutropenia in patients with early stage breast cancer.
An assessment of more than 71,000 patients with leukemia demonstrated the difference in outcomes for patients admitted to hospital on the weekend vs weekday. Findings were presented at the 2018 ASCO Annual Meeting.
An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.
Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.
Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.
Children's Oncology Group study reported on the effect of dexrazoxane on cardiotoxicity of anthracycline-containing regimens in pediatric patients with AML at the 2018 ASCO Annual Meeting.
In a multicenter phase 2 study, the Walk With Ease program was evaluated for its effectiveness in reducing radiotherapy-associated fatigue vs usual care in older patients with breast cancer. Results were presented at 2018 ASCO Annual Meeting.
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
Duvelisib, a first-in-class dual inhibitor of PI3K-delta and -gamma, was evaluated in patients with relapsed/refractory CLL/SLL and in patients with refractory indolent non-Hodgkin lymphoma.
Researchers evaluated whether age is a predictor of pain response after radiotherapy for painful bone metastasis among 128 patients undergoing palliative radiotherapy.
Study presented at 2018 ASCO Annual Meeting determined the feasibility of using a mindfulness intervention to improve quality of life and confidence in advance care planning discussions among patient-family caregiver dyads.
The addition of mitoxantrone and prednisone (MP) to adjuvant androgen-deprivation therapy did not increase survival among patients with high-risk prostate cancer.
Consultations for palliative care for hospitalized highly symptomatic patients with cancer is low regardless of curability or whether patient has hematologic or solid cancer, a study presented at 2018 ASCO has shown.
Sarcopenia and adiposity measures may help clinicians steer management strategies for some patients with breast cancer.
Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.
The ability to make early adjustments to treatment has the potential to improve survival.
Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.
In a case study, olaparib was found to induce folate deficiency in most patients with relapsed ovarian cancer. Researchers discuss the significance of this adverse effect and how it was managed.
Outcomes assessment of patients participating in several different trials quantified the effect of nausea and vomiting separately, and on both the patient and the caregiver.
A phase 2 study determined if adding bevacizumab or temsirolimus to PC, or an ixabepilone/carboplatin/bevacizumab combination will increase progression-free survival for women with advanced/recurrent endometrial cancer, compared with PC alone.
Researchers observed a decrease in the age-specific incidence of lung cancer among both men and women aged 30 to 54 years over the past two decades; the declines among men were steeper.
High-certainty evidence for cervical cancer protection in adolescent girls and young women aged 15 to 26 years.
A meta-analysis of 11 studies revealed the effects of smoking outcomes of primary radical radiotherapy or radical prostatectomy for prostate cancer.
In the period from 2008 to 2016, advanced practice clinician employment increased significantly in physician practices.
Researchers merged data from the Oslo diet and antismoking study with data from the Cancer Registry of Norway and the Norwegian Cause of Death Registry to determine if lifestyle changes that improved CHD rates in men would be as effective against cancer.
In a follow-up to the Women's Health Initiative study, researchers determined the effect of a low-fat diet on overall survival after a breast cancer diagnosis.
A review examines the evidence and current practices pertaining to the use of intrathecal drug delivery systems (IDDS) and spinal cord stimulation (SCS) to address cancer pain.
Researchers report on a study investigating effects of ADT on prostate cancer health-related quality of life, sexual function, sexual bother, and mood for patients with prostate cancer and their partners.
Investigators sought to determine the impact on quality of life for patients with relapsed/refractory multiple myeloma treated with PAN and BTZ+DEX.
Interestingly, red and white wine to not affect prostate cancer risk the same way.
Researchers conducted a retrospective cohort analysis to examine patterns of clinical practice in the management of women with advanced HGSC.
In fielding reports of CNS-related adverse effects from patients in the ambulatory infusion room, nurses were able to prompt a pharmacy practice review. The outcomes of the resulting switch in premedication for HSR was presented at the 2018 ONS Annual Congress.
Long-term neurotoxicity was more frequently seen with cisplatin than with vinca alkaloids, data indicates.
A clinic staffed with clinical research nurses provided needed care for patients in clinical trials who experienced adverse effects, and also ensured consistent documentation of treatment-related AEs, according to a presentation at the 2018 ONS Annual Congress.
Researchers reported on their study that investigated the feasibility of operating a same-day clinic for urgent care for patients currently receiving cancer treatment. These results were presented at the 2018 ONS Annual Congress.
The US FDA granted approval based on results from ARIEL3, a randomized clinical trial conducted with 561 eligible cancer patients.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|